Increased serum cathepsin S in patients with atherosclerosis and diabetes
Open Access
- 30 June 2006
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 186 (2) , 411-419
- https://doi.org/10.1016/j.atherosclerosis.2005.08.001
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Comparative performance of serum cystatin-c versus serum creatinine in diabetic subjectsDiabetes & Metabolism, 2003
- Extracellular proteolysis in the development and progression of atherosclerosisBiochemical Society Transactions, 2002
- Short- and long-term effects of atorvastatin, lovastatin and simvastatin on the cellular metabolism of cholesteryl esters and VLDL secretion in rat hepatocytesAtherosclerosis, 2000
- Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosisExpert Opinion on Investigational Drugs, 2000
- Diabetic dyslipidaemia and coronary heart diseaseCurrent Opinion in Lipidology, 1999
- Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease, Especially in Non–Insulin-Dependent Diabetes MellitusArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteriesCardiovascular Research, 1993
- Plasminogen Activation in Diabetes Mellitus: Kinetics of Plasmin Formation with Plasminogen and Tissue Plasminogen Activator from Diabetic DonorsSeminars in Thrombosis and Hemostasis, 1991
- Diabetes and Atherosclerosis Metabolic LinksDrugs, 1988
- Comparison of live human neutrophil and alveolar macrophage elastolytic activity in vitro. Relative resistance of macrophage elastolytic activity to serum and alveolar proteinase inhibitors.Journal of Clinical Investigation, 1984